Half of the genes are unknown and the other half include representatives of most known cancer processes. Pathogenesis of ovarian cancers. An understanding of the molecular events involved in the pathogenesis of epithelial ovarian cancer is beginning to evolve. Improvements in early diagnosis, treatment, and prevention of this deadly disease are dependent on further progress in this area. The apoptotic engine acts as a regulatory mechanism by allowing healthy cells to proliferate while encouraging damaged cells to kill themselves .
Tumor cells proliferate when that engine fails to operate.
Potential methods of repair include finding chemicals that target receptors to restore the apoptotic function in tumor cells, inducing apoptosis in a tumor's developing blood vessel, and imitating apoptosis through the introduction of engineered bacteria. Our study supports the concept that development of ovarian carcinoma is the end result of a complex multistep process involving the complementary action of different cancer causing genes. This is a summary of the gene therapy progress reported on at the 1996 ASCO conference. This is a broad overview of immunotherapy. This is a summary of progress in immunotherapy.